Skip to main content

Table 10 Fecal Occult Blood (FOB)

From: A randomized, double blind, placebo and active comparator controlled pilot study of UP446, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin

Fecal Occult Blood (FOB)

UP446

250 mgs

UP446

500 mgs

Celecoxib

200 mgs

Placebo

Visit

Baseline

Positive

0

0

0

0

 

30 Days

Positive

0

0

2

1

 

90 Days

Positive

3

5

5

4

Total per study period

3

5

7

5